Pharma & Healthcare
Global Felodipine Extended-Release Tablets Market Research Report 2024
- Sep 18, 24
- ID: 553288
- Pages: 94
- Figures: 94
- Views: 2
Glucosamine Sulfate Chondroitin is a dietary supplement commonly used for bone and joint health care, usually used to relieve joint pain and improve joint function. Its main ingredients include glucosamine (Glucosamine) and chondroitin sulfate (Chondroitin Sulfate).
The global Felodipine Extended-Release Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Felodipine Extended-Release Tablets include Movefree, Pfizer, Watsons, Doppelherz, AdvaCare, By-Health, Blackmores, KAL, Schiff, Zhejiang Cheng Yi Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Felodipine Extended-Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Felodipine Extended-Release Tablets.
The Felodipine Extended-Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Felodipine Extended-Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Felodipine Extended-Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Movefree
Pfizer
Watsons
Doppelherz
AdvaCare
By-Health
Blackmores
KAL
Schiff
Zhejiang Cheng Yi Pharmaceutical
CSPC
Segment by Type
Tablets
Capsules
Segment by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Felodipine Extended-Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Felodipine Extended-Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Felodipine Extended-Release Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Felodipine Extended-Release Tablets include Movefree, Pfizer, Watsons, Doppelherz, AdvaCare, By-Health, Blackmores, KAL, Schiff, Zhejiang Cheng Yi Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Felodipine Extended-Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Felodipine Extended-Release Tablets.
The Felodipine Extended-Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Felodipine Extended-Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Felodipine Extended-Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Movefree
Pfizer
Watsons
Doppelherz
AdvaCare
By-Health
Blackmores
KAL
Schiff
Zhejiang Cheng Yi Pharmaceutical
CSPC
Segment by Type
Tablets
Capsules
Segment by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Felodipine Extended-Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Felodipine Extended-Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Felodipine Extended-Release Tablets Market Overview
1.1 Product Definition
1.2 Felodipine Extended-Release Tablets by Type
1.2.1 Global Felodipine Extended-Release Tablets Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsules
1.3 Felodipine Extended-Release Tablets by Application
1.3.1 Global Felodipine Extended-Release Tablets Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Felodipine Extended-Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Felodipine Extended-Release Tablets Revenue 2019-2030
1.4.2 Global Felodipine Extended-Release Tablets Sales 2019-2030
1.4.3 Global Felodipine Extended-Release Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Felodipine Extended-Release Tablets Market Competition by Manufacturers
2.1 Global Felodipine Extended-Release Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Felodipine Extended-Release Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Felodipine Extended-Release Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Felodipine Extended-Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Felodipine Extended-Release Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Felodipine Extended-Release Tablets, Product Type & Application
2.7 Global Key Manufacturers of Felodipine Extended-Release Tablets, Date of Enter into This Industry
2.8 Global Felodipine Extended-Release Tablets Market Competitive Situation and Trends
2.8.1 Global Felodipine Extended-Release Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Felodipine Extended-Release Tablets Players Market Share by Revenue
2.8.3 Global Felodipine Extended-Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Felodipine Extended-Release Tablets Market Scenario by Region
3.1 Global Felodipine Extended-Release Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Felodipine Extended-Release Tablets Sales by Region: 2019-2030
3.2.1 Global Felodipine Extended-Release Tablets Sales by Region: 2019-2024
3.2.2 Global Felodipine Extended-Release Tablets Sales by Region: 2025-2030
3.3 Global Felodipine Extended-Release Tablets Revenue by Region: 2019-2030
3.3.1 Global Felodipine Extended-Release Tablets Revenue by Region: 2019-2024
3.3.2 Global Felodipine Extended-Release Tablets Revenue by Region: 2025-2030
3.4 North America Felodipine Extended-Release Tablets Market Facts & Figures by Country
3.4.1 North America Felodipine Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Felodipine Extended-Release Tablets Sales by Country (2019-2030)
3.4.3 North America Felodipine Extended-Release Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Felodipine Extended-Release Tablets Market Facts & Figures by Country
3.5.1 Europe Felodipine Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Felodipine Extended-Release Tablets Sales by Country (2019-2030)
3.5.3 Europe Felodipine Extended-Release Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Felodipine Extended-Release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Felodipine Extended-Release Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Felodipine Extended-Release Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Felodipine Extended-Release Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Felodipine Extended-Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Felodipine Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Felodipine Extended-Release Tablets Sales by Country (2019-2030)
3.7.3 Latin America Felodipine Extended-Release Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Felodipine Extended-Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Felodipine Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Felodipine Extended-Release Tablets Sales by Type (2019-2030)
4.1.1 Global Felodipine Extended-Release Tablets Sales by Type (2019-2024)
4.1.2 Global Felodipine Extended-Release Tablets Sales by Type (2025-2030)
4.1.3 Global Felodipine Extended-Release Tablets Sales Market Share by Type (2019-2030)
4.2 Global Felodipine Extended-Release Tablets Revenue by Type (2019-2030)
4.2.1 Global Felodipine Extended-Release Tablets Revenue by Type (2019-2024)
4.2.2 Global Felodipine Extended-Release Tablets Revenue by Type (2025-2030)
4.2.3 Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Felodipine Extended-Release Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Felodipine Extended-Release Tablets Sales by Application (2019-2030)
5.1.1 Global Felodipine Extended-Release Tablets Sales by Application (2019-2024)
5.1.2 Global Felodipine Extended-Release Tablets Sales by Application (2025-2030)
5.1.3 Global Felodipine Extended-Release Tablets Sales Market Share by Application (2019-2030)
5.2 Global Felodipine Extended-Release Tablets Revenue by Application (2019-2030)
5.2.1 Global Felodipine Extended-Release Tablets Revenue by Application (2019-2024)
5.2.2 Global Felodipine Extended-Release Tablets Revenue by Application (2025-2030)
5.2.3 Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Felodipine Extended-Release Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Movefree
6.1.1 Movefree Company Information
6.1.2 Movefree Description and Business Overview
6.1.3 Movefree Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Movefree Felodipine Extended-Release Tablets Product Portfolio
6.1.5 Movefree Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Felodipine Extended-Release Tablets Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Watsons
6.3.1 Watsons Company Information
6.3.2 Watsons Description and Business Overview
6.3.3 Watsons Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Watsons Felodipine Extended-Release Tablets Product Portfolio
6.3.5 Watsons Recent Developments/Updates
6.4 Doppelherz
6.4.1 Doppelherz Company Information
6.4.2 Doppelherz Description and Business Overview
6.4.3 Doppelherz Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Doppelherz Felodipine Extended-Release Tablets Product Portfolio
6.4.5 Doppelherz Recent Developments/Updates
6.5 AdvaCare
6.5.1 AdvaCare Company Information
6.5.2 AdvaCare Description and Business Overview
6.5.3 AdvaCare Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AdvaCare Felodipine Extended-Release Tablets Product Portfolio
6.5.5 AdvaCare Recent Developments/Updates
6.6 By-Health
6.6.1 By-Health Company Information
6.6.2 By-Health Description and Business Overview
6.6.3 By-Health Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 By-Health Felodipine Extended-Release Tablets Product Portfolio
6.6.5 By-Health Recent Developments/Updates
6.7 Blackmores
6.7.1 Blackmores Company Information
6.7.2 Blackmores Description and Business Overview
6.7.3 Blackmores Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Blackmores Felodipine Extended-Release Tablets Product Portfolio
6.7.5 Blackmores Recent Developments/Updates
6.8 KAL
6.8.1 KAL Company Information
6.8.2 KAL Description and Business Overview
6.8.3 KAL Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 KAL Felodipine Extended-Release Tablets Product Portfolio
6.8.5 KAL Recent Developments/Updates
6.9 Schiff
6.9.1 Schiff Company Information
6.9.2 Schiff Description and Business Overview
6.9.3 Schiff Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Schiff Felodipine Extended-Release Tablets Product Portfolio
6.9.5 Schiff Recent Developments/Updates
6.10 Zhejiang Cheng Yi Pharmaceutical
6.10.1 Zhejiang Cheng Yi Pharmaceutical Company Information
6.10.2 Zhejiang Cheng Yi Pharmaceutical Description and Business Overview
6.10.3 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio
6.10.5 Zhejiang Cheng Yi Pharmaceutical Recent Developments/Updates
6.11 CSPC
6.11.1 CSPC Company Information
6.11.2 CSPC Description and Business Overview
6.11.3 CSPC Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CSPC Felodipine Extended-Release Tablets Product Portfolio
6.11.5 CSPC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Felodipine Extended-Release Tablets Industry Chain Analysis
7.2 Felodipine Extended-Release Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Felodipine Extended-Release Tablets Production Mode & Process
7.4 Felodipine Extended-Release Tablets Sales and Marketing
7.4.1 Felodipine Extended-Release Tablets Sales Channels
7.4.2 Felodipine Extended-Release Tablets Distributors
7.5 Felodipine Extended-Release Tablets Customers
8 Felodipine Extended-Release Tablets Market Dynamics
8.1 Felodipine Extended-Release Tablets Industry Trends
8.2 Felodipine Extended-Release Tablets Market Drivers
8.3 Felodipine Extended-Release Tablets Market Challenges
8.4 Felodipine Extended-Release Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Felodipine Extended-Release Tablets by Type
1.2.1 Global Felodipine Extended-Release Tablets Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsules
1.3 Felodipine Extended-Release Tablets by Application
1.3.1 Global Felodipine Extended-Release Tablets Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Felodipine Extended-Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Felodipine Extended-Release Tablets Revenue 2019-2030
1.4.2 Global Felodipine Extended-Release Tablets Sales 2019-2030
1.4.3 Global Felodipine Extended-Release Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Felodipine Extended-Release Tablets Market Competition by Manufacturers
2.1 Global Felodipine Extended-Release Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Felodipine Extended-Release Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Felodipine Extended-Release Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Felodipine Extended-Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Felodipine Extended-Release Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Felodipine Extended-Release Tablets, Product Type & Application
2.7 Global Key Manufacturers of Felodipine Extended-Release Tablets, Date of Enter into This Industry
2.8 Global Felodipine Extended-Release Tablets Market Competitive Situation and Trends
2.8.1 Global Felodipine Extended-Release Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Felodipine Extended-Release Tablets Players Market Share by Revenue
2.8.3 Global Felodipine Extended-Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Felodipine Extended-Release Tablets Market Scenario by Region
3.1 Global Felodipine Extended-Release Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Felodipine Extended-Release Tablets Sales by Region: 2019-2030
3.2.1 Global Felodipine Extended-Release Tablets Sales by Region: 2019-2024
3.2.2 Global Felodipine Extended-Release Tablets Sales by Region: 2025-2030
3.3 Global Felodipine Extended-Release Tablets Revenue by Region: 2019-2030
3.3.1 Global Felodipine Extended-Release Tablets Revenue by Region: 2019-2024
3.3.2 Global Felodipine Extended-Release Tablets Revenue by Region: 2025-2030
3.4 North America Felodipine Extended-Release Tablets Market Facts & Figures by Country
3.4.1 North America Felodipine Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Felodipine Extended-Release Tablets Sales by Country (2019-2030)
3.4.3 North America Felodipine Extended-Release Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Felodipine Extended-Release Tablets Market Facts & Figures by Country
3.5.1 Europe Felodipine Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Felodipine Extended-Release Tablets Sales by Country (2019-2030)
3.5.3 Europe Felodipine Extended-Release Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Felodipine Extended-Release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Felodipine Extended-Release Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Felodipine Extended-Release Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Felodipine Extended-Release Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Felodipine Extended-Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Felodipine Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Felodipine Extended-Release Tablets Sales by Country (2019-2030)
3.7.3 Latin America Felodipine Extended-Release Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Felodipine Extended-Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Felodipine Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Felodipine Extended-Release Tablets Sales by Type (2019-2030)
4.1.1 Global Felodipine Extended-Release Tablets Sales by Type (2019-2024)
4.1.2 Global Felodipine Extended-Release Tablets Sales by Type (2025-2030)
4.1.3 Global Felodipine Extended-Release Tablets Sales Market Share by Type (2019-2030)
4.2 Global Felodipine Extended-Release Tablets Revenue by Type (2019-2030)
4.2.1 Global Felodipine Extended-Release Tablets Revenue by Type (2019-2024)
4.2.2 Global Felodipine Extended-Release Tablets Revenue by Type (2025-2030)
4.2.3 Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Felodipine Extended-Release Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Felodipine Extended-Release Tablets Sales by Application (2019-2030)
5.1.1 Global Felodipine Extended-Release Tablets Sales by Application (2019-2024)
5.1.2 Global Felodipine Extended-Release Tablets Sales by Application (2025-2030)
5.1.3 Global Felodipine Extended-Release Tablets Sales Market Share by Application (2019-2030)
5.2 Global Felodipine Extended-Release Tablets Revenue by Application (2019-2030)
5.2.1 Global Felodipine Extended-Release Tablets Revenue by Application (2019-2024)
5.2.2 Global Felodipine Extended-Release Tablets Revenue by Application (2025-2030)
5.2.3 Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Felodipine Extended-Release Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Movefree
6.1.1 Movefree Company Information
6.1.2 Movefree Description and Business Overview
6.1.3 Movefree Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Movefree Felodipine Extended-Release Tablets Product Portfolio
6.1.5 Movefree Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Felodipine Extended-Release Tablets Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Watsons
6.3.1 Watsons Company Information
6.3.2 Watsons Description and Business Overview
6.3.3 Watsons Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Watsons Felodipine Extended-Release Tablets Product Portfolio
6.3.5 Watsons Recent Developments/Updates
6.4 Doppelherz
6.4.1 Doppelherz Company Information
6.4.2 Doppelherz Description and Business Overview
6.4.3 Doppelherz Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Doppelherz Felodipine Extended-Release Tablets Product Portfolio
6.4.5 Doppelherz Recent Developments/Updates
6.5 AdvaCare
6.5.1 AdvaCare Company Information
6.5.2 AdvaCare Description and Business Overview
6.5.3 AdvaCare Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AdvaCare Felodipine Extended-Release Tablets Product Portfolio
6.5.5 AdvaCare Recent Developments/Updates
6.6 By-Health
6.6.1 By-Health Company Information
6.6.2 By-Health Description and Business Overview
6.6.3 By-Health Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 By-Health Felodipine Extended-Release Tablets Product Portfolio
6.6.5 By-Health Recent Developments/Updates
6.7 Blackmores
6.7.1 Blackmores Company Information
6.7.2 Blackmores Description and Business Overview
6.7.3 Blackmores Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Blackmores Felodipine Extended-Release Tablets Product Portfolio
6.7.5 Blackmores Recent Developments/Updates
6.8 KAL
6.8.1 KAL Company Information
6.8.2 KAL Description and Business Overview
6.8.3 KAL Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 KAL Felodipine Extended-Release Tablets Product Portfolio
6.8.5 KAL Recent Developments/Updates
6.9 Schiff
6.9.1 Schiff Company Information
6.9.2 Schiff Description and Business Overview
6.9.3 Schiff Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Schiff Felodipine Extended-Release Tablets Product Portfolio
6.9.5 Schiff Recent Developments/Updates
6.10 Zhejiang Cheng Yi Pharmaceutical
6.10.1 Zhejiang Cheng Yi Pharmaceutical Company Information
6.10.2 Zhejiang Cheng Yi Pharmaceutical Description and Business Overview
6.10.3 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio
6.10.5 Zhejiang Cheng Yi Pharmaceutical Recent Developments/Updates
6.11 CSPC
6.11.1 CSPC Company Information
6.11.2 CSPC Description and Business Overview
6.11.3 CSPC Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CSPC Felodipine Extended-Release Tablets Product Portfolio
6.11.5 CSPC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Felodipine Extended-Release Tablets Industry Chain Analysis
7.2 Felodipine Extended-Release Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Felodipine Extended-Release Tablets Production Mode & Process
7.4 Felodipine Extended-Release Tablets Sales and Marketing
7.4.1 Felodipine Extended-Release Tablets Sales Channels
7.4.2 Felodipine Extended-Release Tablets Distributors
7.5 Felodipine Extended-Release Tablets Customers
8 Felodipine Extended-Release Tablets Market Dynamics
8.1 Felodipine Extended-Release Tablets Industry Trends
8.2 Felodipine Extended-Release Tablets Market Drivers
8.3 Felodipine Extended-Release Tablets Market Challenges
8.4 Felodipine Extended-Release Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Felodipine Extended-Release Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Felodipine Extended-Release Tablets Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Felodipine Extended-Release Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Felodipine Extended-Release Tablets Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Felodipine Extended-Release Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Felodipine Extended-Release Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Felodipine Extended-Release Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Felodipine Extended-Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Felodipine Extended-Release Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Felodipine Extended-Release Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Felodipine Extended-Release Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Felodipine Extended-Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Felodipine Extended-Release Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Felodipine Extended-Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Felodipine Extended-Release Tablets Sales by Region (2019-2024) & (K Units)
Table 18. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Felodipine Extended-Release Tablets Sales by Region (2025-2030) & (K Units)
Table 20. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Felodipine Extended-Release Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Felodipine Extended-Release Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Felodipine Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Felodipine Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
Table 27. North America Felodipine Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
Table 28. North America Felodipine Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Felodipine Extended-Release Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Felodipine Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Felodipine Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
Table 32. Europe Felodipine Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
Table 33. Europe Felodipine Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Felodipine Extended-Release Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Felodipine Extended-Release Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Felodipine Extended-Release Tablets Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Felodipine Extended-Release Tablets Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Felodipine Extended-Release Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Felodipine Extended-Release Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Felodipine Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Felodipine Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Felodipine Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Felodipine Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Felodipine Extended-Release Tablets Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Felodipine Extended-Release Tablets Sales (K Units) by Type (2019-2024)
Table 51. Global Felodipine Extended-Release Tablets Sales (K Units) by Type (2025-2030)
Table 52. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Type (2019-2024)
Table 59. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Type (2025-2030)
Table 60. Global Felodipine Extended-Release Tablets Sales (K Units) by Application (2019-2024)
Table 61. Global Felodipine Extended-Release Tablets Sales (K Units) by Application (2025-2030)
Table 62. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Application (2019-2024)
Table 69. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Application (2025-2030)
Table 70. Movefree Company Information
Table 71. Movefree Description and Business Overview
Table 72. Movefree Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Movefree Felodipine Extended-Release Tablets Product
Table 74. Movefree Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Felodipine Extended-Release Tablets Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Watsons Company Information
Table 81. Watsons Description and Business Overview
Table 82. Watsons Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Watsons Felodipine Extended-Release Tablets Product
Table 84. Watsons Recent Developments/Updates
Table 85. Doppelherz Company Information
Table 86. Doppelherz Description and Business Overview
Table 87. Doppelherz Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Doppelherz Felodipine Extended-Release Tablets Product
Table 89. Doppelherz Recent Developments/Updates
Table 90. AdvaCare Company Information
Table 91. AdvaCare Description and Business Overview
Table 92. AdvaCare Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. AdvaCare Felodipine Extended-Release Tablets Product
Table 94. AdvaCare Recent Developments/Updates
Table 95. By-Health Company Information
Table 96. By-Health Description and Business Overview
Table 97. By-Health Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. By-Health Felodipine Extended-Release Tablets Product
Table 99. By-Health Recent Developments/Updates
Table 100. Blackmores Company Information
Table 101. Blackmores Description and Business Overview
Table 102. Blackmores Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Blackmores Felodipine Extended-Release Tablets Product
Table 104. Blackmores Recent Developments/Updates
Table 105. KAL Company Information
Table 106. KAL Description and Business Overview
Table 107. KAL Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. KAL Felodipine Extended-Release Tablets Product
Table 109. KAL Recent Developments/Updates
Table 110. Schiff Company Information
Table 111. Schiff Description and Business Overview
Table 112. Schiff Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Schiff Felodipine Extended-Release Tablets Product
Table 114. Schiff Recent Developments/Updates
Table 115. Zhejiang Cheng Yi Pharmaceutical Company Information
Table 116. Zhejiang Cheng Yi Pharmaceutical Description and Business Overview
Table 117. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product
Table 119. Zhejiang Cheng Yi Pharmaceutical Recent Developments/Updates
Table 120. CSPC Company Information
Table 121. CSPC Description and Business Overview
Table 122. CSPC Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. CSPC Felodipine Extended-Release Tablets Product
Table 124. CSPC Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Felodipine Extended-Release Tablets Distributors List
Table 128. Felodipine Extended-Release Tablets Customers List
Table 129. Felodipine Extended-Release Tablets Market Trends
Table 130. Felodipine Extended-Release Tablets Market Drivers
Table 131. Felodipine Extended-Release Tablets Market Challenges
Table 132. Felodipine Extended-Release Tablets Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Felodipine Extended-Release Tablets
Figure 2. Global Felodipine Extended-Release Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Felodipine Extended-Release Tablets Market Share by Type: 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Felodipine Extended-Release Tablets Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Felodipine Extended-Release Tablets Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Global Felodipine Extended-Release Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Felodipine Extended-Release Tablets Market Size (2019-2030) & (US$ Million)
Figure 13. Global Felodipine Extended-Release Tablets Sales (2019-2030) & (K Units)
Figure 14. Global Felodipine Extended-Release Tablets Average Price (US$/Unit) & (2019-2030)
Figure 15. Felodipine Extended-Release Tablets Report Years Considered
Figure 16. Felodipine Extended-Release Tablets Sales Share by Manufacturers in 2023
Figure 17. Global Felodipine Extended-Release Tablets Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Felodipine Extended-Release Tablets Players: Market Share by Revenue in Felodipine Extended-Release Tablets in 2023
Figure 19. Felodipine Extended-Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Felodipine Extended-Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Felodipine Extended-Release Tablets Sales Market Share by Country (2019-2030)
Figure 22. North America Felodipine Extended-Release Tablets Revenue Market Share by Country (2019-2030)
Figure 23. United States Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Felodipine Extended-Release Tablets Sales Market Share by Country (2019-2030)
Figure 26. Europe Felodipine Extended-Release Tablets Revenue Market Share by Country (2019-2030)
Figure 27. Germany Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Felodipine Extended-Release Tablets Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Felodipine Extended-Release Tablets Revenue Market Share by Region (2019-2030)
Figure 34. China Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Felodipine Extended-Release Tablets Sales Market Share by Country (2019-2030)
Figure 42. Mexico Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Felodipine Extended-Release Tablets Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Felodipine Extended-Release Tablets Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Felodipine Extended-Release Tablets by Type (2019-2030)
Figure 52. Global Revenue Market Share of Felodipine Extended-Release Tablets by Type (2019-2030)
Figure 53. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Felodipine Extended-Release Tablets by Application (2019-2030)
Figure 55. Global Revenue Market Share of Felodipine Extended-Release Tablets by Application (2019-2030)
Figure 56. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Application (2019-2030)
Figure 57. Felodipine Extended-Release Tablets Value Chain
Figure 58. Felodipine Extended-Release Tablets Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Felodipine Extended-Release Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Felodipine Extended-Release Tablets Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Felodipine Extended-Release Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Felodipine Extended-Release Tablets Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Felodipine Extended-Release Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Felodipine Extended-Release Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Felodipine Extended-Release Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Felodipine Extended-Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Felodipine Extended-Release Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Felodipine Extended-Release Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Felodipine Extended-Release Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Felodipine Extended-Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Felodipine Extended-Release Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Felodipine Extended-Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Felodipine Extended-Release Tablets Sales by Region (2019-2024) & (K Units)
Table 18. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Felodipine Extended-Release Tablets Sales by Region (2025-2030) & (K Units)
Table 20. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Felodipine Extended-Release Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Felodipine Extended-Release Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Felodipine Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Felodipine Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
Table 27. North America Felodipine Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
Table 28. North America Felodipine Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Felodipine Extended-Release Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Felodipine Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Felodipine Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
Table 32. Europe Felodipine Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
Table 33. Europe Felodipine Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Felodipine Extended-Release Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Felodipine Extended-Release Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Felodipine Extended-Release Tablets Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Felodipine Extended-Release Tablets Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Felodipine Extended-Release Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Felodipine Extended-Release Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Felodipine Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Felodipine Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Felodipine Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Felodipine Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Felodipine Extended-Release Tablets Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Felodipine Extended-Release Tablets Sales (K Units) by Type (2019-2024)
Table 51. Global Felodipine Extended-Release Tablets Sales (K Units) by Type (2025-2030)
Table 52. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Type (2019-2024)
Table 59. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Type (2025-2030)
Table 60. Global Felodipine Extended-Release Tablets Sales (K Units) by Application (2019-2024)
Table 61. Global Felodipine Extended-Release Tablets Sales (K Units) by Application (2025-2030)
Table 62. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Felodipine Extended-Release Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Application (2019-2024)
Table 69. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Application (2025-2030)
Table 70. Movefree Company Information
Table 71. Movefree Description and Business Overview
Table 72. Movefree Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Movefree Felodipine Extended-Release Tablets Product
Table 74. Movefree Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Felodipine Extended-Release Tablets Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Watsons Company Information
Table 81. Watsons Description and Business Overview
Table 82. Watsons Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Watsons Felodipine Extended-Release Tablets Product
Table 84. Watsons Recent Developments/Updates
Table 85. Doppelherz Company Information
Table 86. Doppelherz Description and Business Overview
Table 87. Doppelherz Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Doppelherz Felodipine Extended-Release Tablets Product
Table 89. Doppelherz Recent Developments/Updates
Table 90. AdvaCare Company Information
Table 91. AdvaCare Description and Business Overview
Table 92. AdvaCare Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. AdvaCare Felodipine Extended-Release Tablets Product
Table 94. AdvaCare Recent Developments/Updates
Table 95. By-Health Company Information
Table 96. By-Health Description and Business Overview
Table 97. By-Health Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. By-Health Felodipine Extended-Release Tablets Product
Table 99. By-Health Recent Developments/Updates
Table 100. Blackmores Company Information
Table 101. Blackmores Description and Business Overview
Table 102. Blackmores Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Blackmores Felodipine Extended-Release Tablets Product
Table 104. Blackmores Recent Developments/Updates
Table 105. KAL Company Information
Table 106. KAL Description and Business Overview
Table 107. KAL Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. KAL Felodipine Extended-Release Tablets Product
Table 109. KAL Recent Developments/Updates
Table 110. Schiff Company Information
Table 111. Schiff Description and Business Overview
Table 112. Schiff Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Schiff Felodipine Extended-Release Tablets Product
Table 114. Schiff Recent Developments/Updates
Table 115. Zhejiang Cheng Yi Pharmaceutical Company Information
Table 116. Zhejiang Cheng Yi Pharmaceutical Description and Business Overview
Table 117. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product
Table 119. Zhejiang Cheng Yi Pharmaceutical Recent Developments/Updates
Table 120. CSPC Company Information
Table 121. CSPC Description and Business Overview
Table 122. CSPC Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. CSPC Felodipine Extended-Release Tablets Product
Table 124. CSPC Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Felodipine Extended-Release Tablets Distributors List
Table 128. Felodipine Extended-Release Tablets Customers List
Table 129. Felodipine Extended-Release Tablets Market Trends
Table 130. Felodipine Extended-Release Tablets Market Drivers
Table 131. Felodipine Extended-Release Tablets Market Challenges
Table 132. Felodipine Extended-Release Tablets Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Felodipine Extended-Release Tablets
Figure 2. Global Felodipine Extended-Release Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Felodipine Extended-Release Tablets Market Share by Type: 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Felodipine Extended-Release Tablets Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Felodipine Extended-Release Tablets Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Global Felodipine Extended-Release Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Felodipine Extended-Release Tablets Market Size (2019-2030) & (US$ Million)
Figure 13. Global Felodipine Extended-Release Tablets Sales (2019-2030) & (K Units)
Figure 14. Global Felodipine Extended-Release Tablets Average Price (US$/Unit) & (2019-2030)
Figure 15. Felodipine Extended-Release Tablets Report Years Considered
Figure 16. Felodipine Extended-Release Tablets Sales Share by Manufacturers in 2023
Figure 17. Global Felodipine Extended-Release Tablets Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Felodipine Extended-Release Tablets Players: Market Share by Revenue in Felodipine Extended-Release Tablets in 2023
Figure 19. Felodipine Extended-Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Felodipine Extended-Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Felodipine Extended-Release Tablets Sales Market Share by Country (2019-2030)
Figure 22. North America Felodipine Extended-Release Tablets Revenue Market Share by Country (2019-2030)
Figure 23. United States Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Felodipine Extended-Release Tablets Sales Market Share by Country (2019-2030)
Figure 26. Europe Felodipine Extended-Release Tablets Revenue Market Share by Country (2019-2030)
Figure 27. Germany Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Felodipine Extended-Release Tablets Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Felodipine Extended-Release Tablets Revenue Market Share by Region (2019-2030)
Figure 34. China Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Felodipine Extended-Release Tablets Sales Market Share by Country (2019-2030)
Figure 42. Mexico Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Felodipine Extended-Release Tablets Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Felodipine Extended-Release Tablets Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Felodipine Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Felodipine Extended-Release Tablets by Type (2019-2030)
Figure 52. Global Revenue Market Share of Felodipine Extended-Release Tablets by Type (2019-2030)
Figure 53. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Felodipine Extended-Release Tablets by Application (2019-2030)
Figure 55. Global Revenue Market Share of Felodipine Extended-Release Tablets by Application (2019-2030)
Figure 56. Global Felodipine Extended-Release Tablets Price (US$/Unit) by Application (2019-2030)
Figure 57. Felodipine Extended-Release Tablets Value Chain
Figure 58. Felodipine Extended-Release Tablets Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232